Cynthia Yee is a Principal at Windham Venture Partners. Cynthia led Windham’s investments in Cartiva and ClarVista Medical and is currently Director at ClarVista Medical. Prior to joining Windham, Cynthia served as Director of Business Development & Strategic Marketing at Advanced Cardiac Therapeutics (ACT), a venture-backed medical device start-up.  Previously, she was an Associate on the Healthcare team at New Enterprise Associates (NEA) and focused on investments in medical device, biopharmaceutical and healthcare services companies. At NEA, Cynthia helped allocate over $250M in capital to healthcare companies in the peripheral and cardiovascular, spine, diabetes, urology and women’s health industries. Cynthia began her career in equity research, covering medical devices at Piper Jaffray and biopharma at Pacific Growth Equities.

Cynthia graduated from the University of California, Berkeley, where she earned a BA in Integrative Biology with a focus on Human Biology & Health Sciences, and a BS in Business Administration from the Haas School of Business.

Fund's investment verticals: healthcare, medical technology and digital health.